pentacyanoferrate (ii) has been researched along with clenbuterol in 1 studies
| Studies (pentacyanoferrate (ii)) | Trials (pentacyanoferrate (ii)) | Recent Studies (post-2010) (pentacyanoferrate (ii)) | Studies (clenbuterol) | Trials (clenbuterol) | Recent Studies (post-2010) (clenbuterol) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 1,506 | 89 | 370 |
| Protein | Taxonomy | pentacyanoferrate (ii) (IC50) | clenbuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 0.6705 | |
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.12 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.652 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.652 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bories, G; Debrauwer, L; Tulliez, J; Zalko, D | 1 |
1 other study(ies) available for pentacyanoferrate (ii) and clenbuterol
| Article | Year |
|---|---|
Evidence for a new and major metabolic pathway clenbuterol involving in vivo formation of an N-hydroxyarylamine.
Topics: Administration, Oral; Animals; Chromatography, High Pressure Liquid; Clenbuterol; Drug Stability; Ferricyanides; Ferrous Compounds; Hydroxylamines; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Microsomes, Liver; Organometallic Compounds; Rats; Rats, Wistar | 1997 |